COVID-19 Resources

Due to the high number of inquiries received and the continuous developments regarding the virus, TAG is offering COVID-19 Retainer Packages to businesses concerned with the impact of this outbreak.

Request a quote below or call us: 1-800-401-2239

For the food industry

  • Daily Updates

  • Advice for Food Industry

  • What can you (we) all do?

 
Key Points

Updated: May 07, 2020

In case you missed it:

 
Recommendations for
the Food Industry

from Friday May 08, 2020

Antibody Tests as a Wellness Screening Tool?

We’ve started to see some testing companies advertising antibody tests as a potential employee screening tool to detect infected asymptomatic people.  These tests claim detection of IgM antibodies can be used to find “those in early stages of infection” and that these tests can be completed in less than 20 minutes for rapid onsite diagnosis.

It’s important to recognize that antibody development occurs later in infection and this type of serological testing isn’t recognized by the FDA as a diagnostic test.  In mid-April FDA specifically stated:

“However, some test developers have misused the serology test kit notification list to falsely claim their serological tests are FDA approved or authorized. Others have falsely claimed that their tests can diagnose COVID-19. When we become aware of these issues, we have and will continue to take appropriate action against firms making or distributing unvalidated tests or those making false claims, such as issuing Warning Letters requesting that companies stop their unlawful promotion and detaining and refusing fraudulent test kits at the border.”

Developing accurate and rapid point-of-use diagnostic testing will help employers, clinicians, and public health officials identify and isolate help asymptomatic carriers of COVID-19 and limit the risk of transmission.  Many companies are attempting to develop this kind of diagnostic test and these tests will need to be both sensitive and specific to minimize the number of false positives and false negatives associated with widescale testing.  This will also likely require people to be tested on a fairly frequent basis since their exposure status can change quickly; especially as society beings to “reopen” in the coming weeks and months. 

If you or your company is approached and encouraged to consider workplace testing for COVID-19, reach out to TAG to help independently evaluate the risks and benefits of testing programs and technologies. 

 

Keep up to date with COVID-19:

Please send us any questions, comments, and/or concerns! We are happy to talk with you. 

 

OR call us at 1-800-401-2239

Learn how TAG can help your company ensure food safety and brand protection.

Contact us today!

CONTACT US

info@achesongroup.com

Toll free 800.401.2239

  • White Twitter Icon
  • White LinkedIn Icon
WEEKLY NEWSLeTTER

Join our e-mail list to receive

our weekly Industry Insights!

© 2020 The Acheson Group. All Rights Reserved.